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Salmonella enterica is a foodborne pathogen that causes gastroenteritis, leading to 
approximately 19,000 hospitalizations and 380 deaths each year in the United States. Current 
efforts to develop new drugs aim to disrupt pathways important to the bacteria’s fitness during 
infection. High throughput genetic screening of Salmonella mutants that are less fit in mice has 
identified the fra locus, containing the fraBDAE operon, which confers the ability to metabolize 
fructose-asparagine (F-Asn). Disruption of this pathway, specifically of fraB, is bacteriostatic in 
the presence of F-Asn and causes a significant decrease in Salmonella fitness in mice. The 
observed phenotype is hypothesized to be due to an accumulation of the toxic intermediate 6-
phosphofructose-aspartate (6-P-F-Asp). This has been supported by genetics and mass 
spectroscopy. Our goal was to better understand the mechanism of this toxicity, which has not 
yet been examined. To do so, a library of T-POP transposon insertions was created in a fraB 
mutant background. Mutants were then selected that could grow in minimal media with glucose 
and F-Asn. Several mutants were isolated and classified to identify gene products that alleviate 
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Salmonella enterica is a foodborne pathogen that causes gastroenteritis and diarrhea [1]. 
Approximately one million infections occur in the United States each year, with 19,000 requiring 
hospitalization, and 380 resulting in death. Globally, non-typhoidal Salmonella is responsible for 
tens of millions of infections annually. Healthy individuals can overcome a typical infection in 4-
7 days, but children, the elderly, and immunocompromised individuals may require treatment 
[2]. Severe infections that have entered the bloodstream, or infection of immunocompromised 
individuals, are treated with antibiotics [3]. However, antibiotics are not prescribed to healthy 
individuals. The overuse of antibiotics is a growing threat to public health, as it leads to the 
development of resistant bacteria. Each year, there are at least 23,000 deaths directly caused by 
these resistant bacteria [4].  
One approach to developing new treatment options is designing antimicrobials that 
disrupt genes that are essential to the pathogen’s fitness. High throughput genetic screening has 
been used to identify such genes of Salmonella required for fitness in a mouse model. Any of 
these genes has the potential of being a drug target, but not all of them are appropriate or 
practical. An ideal drug target would be specific to Salmonella, allowing the normal gut 
microbiota to remain intact. The drug should be stable to allow transport, cost effective, and have 
limited side effects. 
Through this screening, the fra locus was discovered as essential for Salmonella fitness in 
mice [5]. Previously uncharacterized, this locus has now been shown to confer the ability to use 
the carbon source fructose-asparagine (F-Asn). The fra locus includes the fraBDAE operon, with 
5 
 
an upstream transcription factor encoded by fraR [5]. As shown in Figures 1 and 2, the operon is 
arranged in opposite order of action of the pathway. The fra locus is specific to Salmonella, and 
was thus further examined as a potential drug target. 
The first step of the pathway is conversion of F-Asn to fructose-aspartate (F-Asp). This 
occurs in the periplasm via the periplasmic asparaginase, FraE. F-Asp is then transported across 
the membrane and into the cytoplasm by the transporter FraA. The sugar kinase, FraD, 
phosphorylates F-Asp, giving the intermediate 6-phosphofructose-aspartate (6-P-F-Asp). Finally, 
6-P-F-Asp is cleaved to aspartate and glucose-6-phosphate by FraB. Glucose-6-phosphate can 
then feed in to central metabolism. 
It was initially believed that the ability to utilize F-Asn was important for Salmonella’s 
fitness in the inflamed intestine [5]. It was suggested that this fitness was provided because F-
Asn could be fermented, or respired with tetrathionate. However, further studies have shown that 
the ability to metabolize F-Asn doesn’t provide higher fitness. Rather, the interruption of the F-
Asn metabolic pathway with a fraB mutation leads to the accumulation of a toxic metabolite, 
significantly decreasing fitness [6]. Figure 3 illustrates this decreased fitness compared to wild-
type when a fraB mutant is grown in the presence of F-Asn.  
This phenotype is hypothesized to be due to the accumulation of the metabolic 
intermediate 6-P-F-Asp. This has been confirmed by measurement of 6-P-F-Asp in wild-type 
and fraB mutant cells using mass spectroscopy. As expected, 6-P-F-Asp accumulated in the fraB 
mutant cells during growth on F-Asn [6]. Thus, FraB offers a potential drug target for treating 
Salmonella. The fra operon also has the advantage of being highly specific, since Salmonella is 
the only organism known to utilize F-Asn. 
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Mutants lacking other genes in the operon have been created, but they are not inhibited 
by F-Asn in vitro, and do not have decreased fitness in mice, due to the lack of 6-P-F-Asp [6]. 
Disruption of fraE only partially disrupts the ability of Salmonella to grow on F-Asn. However, 
double mutants deficient in fraE and ansB, a different periplasmic asparaginase, were unable to 
grow in the presence of F-Asn, suggesting that redundancy makes FraE an inappropriate drug 
target [6]. This leaves FraB as the most viable drug target in the operon.  
The toxicity observed with the accumulation of 6-P-F-Asp may be similar to sugar 
phosphate stress, which has been found to occur in multiple species. In Escherichia coli, cell 
growth is inhibited when disruption of metabolic pathways leads to the accumulation of 
galactose-phosphate or glucose-6-phosphate [7,8]. Growth inhibition due to excess glucose-6-
phosphate has also been shown in Salmonella [7]. In most cases, the mechanism of sugar 
phosphate toxicity has never been determined, but it has been suggested that the phenotype is 
due to the depletion of other metabolites and not the accumulation of the intermediate. 
A mechanism of resistance was recently described via sugar transport related sRNA 
(SgrS) [8]. SgrS plays two important roles in allowing resistance. First, SgrS can regulate 
translation by interacting with mRNA. This interaction can lead to translational repression, often 
resulting in mRNA degradation, or translational activation. In the case of sugar phosphate stress, 
SgrS binds mRNA, repressing ptsG and manXYZ which encode sugar transporters, and activating 
yigL, encoding a phosphatase. SgrS is also translated to give SgrT, which inhibits the PtsG 
transporter. Acting together, this allows the cell to cope with the accumulating sugar-phosphate 
by increasing efflux and inhibiting the uptake of additional sugar-phosphate. 
The main objective of this project was to identify the mechanism of 6-P-F-Asp toxicity in 
Salmonella fraB mutants. To identify mutations that suppress the toxicity of F-Asn, a mutant 
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library was constructed using a T-POP transposon in a fraB mutant background. Mutants were 
then selected that have the ability to grow on glucose and F-Asn with tetracycline. The mutations 
were then transduced back in to a fraB background to reduce the possibility of secondary 







Materials and Methods 
 
Library construction 
A mutant library was created by transducing a T-POP transposon into a fraB mutant 
background. To prepare the lysate, Salmonella typhimurium TH3923 was grown overnight in LB 
at 30˚ C. The cells were washed and subcultured to OD550 of 0.39. 1 mL of 0.5 mg/mL 
mitomycin C was added, and allowed to lyse with shaking at 37˚ C for 4 hours. Mitomycin C 
induces lysogenic bacteria to produce viral particles [9]. The solution was filter sterilized, 
transferred to a glass tube, and 100μL of chloroform was added.  
The transduction was performed immediately after lysate preparation. A 5 mL culture of 
the fraB mutant fraB80::kan carrying the altered target specificity transposase plasmid pNK2880 
was grown in LB with ampicillin at 37˚ C overnight with shaking. In a sterile flask, 5 mL of the 
TH3923 lysate was added to 5 mL of the fraB80::kan culture, and incubated for 25 minutes at 
37˚ C. The cells were washed twice in LB with EGTA, and re-suspended in 50 mL of LB with 
EGTA for a 60 minute outgrowth. The number of mutants in the culture was determined by 
titering on LB with tetracycline. Tetracycline was added to the remaining culture, which was 
allowed to grow at 37˚ C overnight. Two libraries were constructed, the first containing 4,000 
mutants, and the second containing 25,000 mutants. 
Phenotype Selection 
A selection was applied to the library to obtain mutants that could grow in the presence of 
F-Asn. Eleven culture tubes with 5 mL of minimal media with 5 mM glucose, 5 mM F-Asn, 
kanamycin, and tetracycline were each inoculated with 100 μL of library and grown at 37 ˚C 
overnight. Ten cultures were grown from the 25,000 mutant library, and one was grown from the 
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4,000 mutant library. The overnight selections were titered, and 100 μL of each dilution was 
plated on LB with tetracycline and EGTA. One colony was selected from each of the 11 cultures, 
and struck to isolation twice on LB with tetracycline and EGTA. Growth in minimal medium 
with F-Asn and glucose carbon sources was confirmed. The strains were denoted by BMH2XX 
series if selected from the 25,000 mutant library and BMH1XX is selected from the 4,000 mutant 
library. 
Mutant Confirmation and Analysis 
Each mutant was transduced back into wild type Salmonella (14028) and the fraB80::kan 
mutant (HMB206). To do this, P22 phage lysates were made of each mutant. 100 μL of 
overnight culture in LB was added to ten-fold dilutions of P22 phage. 3 mL of top agar was 
added to each infection, plated on LB, and incubated at 37 ˚C overnight. 5 mL of LB broth was 
added to the plate with complete lysis, and shaken overnight at 4 ˚C. The lysate was harvested, 
filter sterilized, and 100 μL of chloroform was added. 
 Overnight cultures of 14028 and HMB206 were started in LB and LB with kanamycin, 
respectively. 100 μL of lysate from each mutant was added to 100 μL of each culture, and 
incubated at 37 ˚C for 25 minutes. Cells were washed with LB with EGTA twice, and 
resuspended in 1 mL of LB with EGTA for a 60 minute outgrowth at 37 ˚C. The outgrowth was 
titered and plated on LB plates with tetracycline, which were incubated at 37 ˚C overnight. 
Colonies from each transduction were struck to isolation on LB plates with EGTA and 
tetracycline twice, and then tested for P22 sensitivity on EBU plates. The resulting strains were 




Phage sensitive colonies from the BMH4XX series were grown in culture and their 
phenotype was confirmed in M9 minimal media with glucose and F-Asn at 37 ˚C for 18 hours. 
OD600 readings were taken every hour by a SpecraMax® M5 Multi-Mode Plate Reader. 
Since the T-POP transposon contains the tetracycline inducible promoters tetA and tetR, 
all mutants were tested for the growth in the presence of F-Asn and tetracycline. This growth 
condition was specifically run to examine BMH414, which was unable to grow in the presence 
of F-Asn following transduction into a fraB mutant background. 
Cotransduction frequency 
 To predict and assist with transposon insertion site identification, colonies were patched 
on LB with kanamycin to calculate the cotransduction frequency of the T-POP mutation with the 
fraB80::kan. The predicted distance of the insertion site from the fra operon was calculated using 
the Wu equation [10]. 
Genomic DNA Preparation and Sequencing 
Genomic DNA from the BMH3XX series was isolated with a GenElute™ Bacterial 
Genomic DNA kit and sent for sequencing at The Plant and Microbe Genomic Facility at The 
Ohio State University.  
Inverse PCR 
 To improve the success rate of sequencing results, inverse PCR was performed on 
isolated genomic DNA from each mutant as described above. The genomic DNA was first 
digested with the restriction enzyme NlaIII in 10X CutSmart® Buffer, 10X BSA, and water. The 
reaction was incubated at 37˚ C for 3 hours, and the enzyme was heat inactivated at 65 ˚C for 20 
minutes. A dilute ligation was performed with the digest mixture in 10X ligase buffer and T4 
DNA ligase at 15 ˚C overnight. The ligation was purified with a QIAprep® Spin Miniprep Kit. 
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The DNA was then digested with DraI in 10X CutSmart® Buffer, 10X BSA, and water. The 
reaction was run at 37 ˚C for 3 hours, and the enzyme was heat inactivated at 65 ˚C for 20 
minutes. Inverse PCR was run with T-POP specific primers. The product was purified with 








 Two libraries containing 4,000 and 25,000 mutants were constructed with the T-POP 
transposon. Mutants were selected for the ability to grow in minimal media with glucose and F-
Asn carbon sources in the presence of tetracycline. Following selection, eleven mutants were 
chosen for further evaluation. They were rescreened for the ability to grow in the presence of F-
Asn. As shown in Figure 4, the ability of all of the mutants to grow on glucose and F-Asn fell in-
between the ability of the wild-type and the fraB mutant.  
Mutations were transduced back into a fraB mutant background and rescreened for the 
ability to grow in the presence of F-Asn and glucose. These mutants were named as BMH4XX 
series. Mutants transduced back into a 14028 background were named as BMH3XX series. 
Figure 5 shows that all but one mutant, BMH414, was able to grow. 
Growth of BMH414 in minimal medial with glucose and F-Asn carbon sources and the 
inducer tetracycline was examined. If the transposon inserted in front of a gene, inducing the 
promoter could alter the mutant’s ability to grow in the presence of F-Asn. However, no change 
was observed, and the strain was discarded. The ten strains able to grow in minimal media with 
glucose and F-Asn were grown again under the same conditions, but with the addition of 
tetracycline. No change was observed in their growth (data not shown). 
 Cotrandsuction frequencies were used to predict the T-POP insertion site distance from 
the fra operon. Table 1 gives the number of kanamycin resistant colonies divided by the total 
number of colonies patched, the calculated cotransduction frequency, the calculated insertion 
distance, and the actual insertion distance, as determined by DNA sequencing, when applicable.  
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Genomic DNA was isolated from each mutant and submitted to sequencing to identify 
the T-POP insertion site. Seven of the eleven mutants were successfully sequenced. Table 2 
gives the interrupted gene and its function for the seven mutants with successful DNA 
sequencing results. Five were found to be located within the fra operon; BMH311, BMH317, 
BMH319 and BMH330 were in fraA and BMH313 was in fraD. Two were located outside the 
operon. BMH310 was in the permease yhhT, and BMH312 was in the glycosyltransferase gtrA.  
Genomic DNA was also used as a template for inverse PCR to increase the success of 
sequencing results. Thus far, only the insertion site in BMH312 has been successfully amplified 





Salmonella enterica is a food-borne pathogen that can cause serious disease in children, 
the elderly, and immunocompromised patients [1,2]. These patients typically require antibiotics 
to treat infection, while healthy individuals can overcome it when untreated [3]. The emergence 
of antibiotic resistant bacteria has necessitated the discovery of novel drug targets to treat 
infection [4]. 
High throughput genetic screening identified Salmonella genes important for fitness in a 
mouse model. This screening identified the fra locus, which confers the ability to metabolize F-
Asn [3]. This locus is specific to Salmonella, making it a promising drug target. This specificity 
would leave commensal gut microbiota intact after treatment, and limit side effects to the patient. 
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Disruption of the fraB gene within the operon leads to a significant decrease in fitness 
caused by accumulation of the metabolic intermediate 6-P-F-Asp. This decreased fitness could 
be similar to sugar phosphate stress. E. coli has been shown to be inhibited by the accumulation 
of galactose-phosphate and glucose-6-phosphate [7,8], and Salmonella has been shown to be 
inhibited by the accumulation of glucose-6-phosphate [7].  
The mechanism of this toxicity is unknown in most cases, but resistance mechanisms 
have been described. Sugar transport related sRNA (SgrS) can either regulate translation directly, 
repressing the sugar transporter genes ptsG and manXYZ, and activating the phosphatase gene 
yigL [8]. SgrS can also be translated to SgrT, which can inhibit the sugar transporter PtsG. These 
mechanisms limit accumulation of the intermediate, and prevent the decreased fitness.  
To determine genes that encode products that may interact with 6-P-F-Asp, a mutant 
library was constructed with the T-POP transposon in a fraB mutant background. Mutants were 
selected for the ability to grow in minimal media with glucose and F-Asn, and further examined 
to identify the interrupted gene. 
Eleven mutants with a suppressed toxicity were chosen for further study. Of the eleven, 
seven have been successfully sequenced. Of these seven, five were within the fra operon. The 
insertion site of BMH311, BMH317, BMH319, and BMH330 was located within the fraA gene, 
encoding the F-Asp transporter FraA. This prevents accumulation of 6-P-F-Asp, since the 
precursor F-Asp cannot be brought into the cell. The insertion site of BMH313 was located 
within fraD, encoding the sugar kinase FraD. Without the kinase, F-Asp is not phosphorylated, 
and there is no accumulation of 6-phosphofructose-aspartate. 
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Following transduction back into the HMB206 background, BMH414 was no longer able 
to grow in the presence of F-Asn. It was grown again with the addition of tetracycline to see if 
the insertion was before a gene that could be induced, but it was still unable to grow. For this 
reason, it was discarded. Possibly, there was a secondary mutation in the original mutant that was 
lost during the transduction into HMB206 that allowed it to grow initially. 
DNA sequencing showed that BMH310 and BMH312 have transposon insertion sites 
24,497 and 1,686,944 base pairs from the fra operon, respectively. P22 phage packages 48kb of 
DNA [11]. This means a cotransduction frequency of 11.8% for BMH310, and 0% for BMH312 
would be expected, according to the Wu equation [10]. However, the actual frequencies were 
60% for BMH310 and 22% for BMH312, suggesting that the insertion was much closer to the 
operon. We hypothesize that BMH312 has an insertion in an uncharacterized phage gene near 
the fra operon; this would account for the discrepancy between the cotransduction frequency and 
the DNA sequencing. If the actual insertion site is known, there should be an exact match in the 
database. But instead, there was only a 92% match between the sequenced genomic DNA of 
BMH312 and NCBI BLASTn, suggesting that the uncharacterized gene is similar, but not 
identical, to gtrA. It is possible that there is a related phage closer to the fra locus that is not 
present in the published genome sequence. 
The success and accuracy of the sequencing will be improved by submitting inverse PCR 
product instead of genomic DNA. BMH310 had only a short sequence match with the yhhT 
gene, and BMH312 had a high rate of dissimilarity to the gtrA gene. This dissimilarity could be 
due to the fact that the insertion is in an uncharacterized phage gene, as previously discussed, due 
to differences in laboratory strains, or sequencing error. Inverse PCR sequencing showed the 
same insertion site as genomic DNA sequencing for BMH312. However, there is still only a 92% 
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match, suggesting this is not due to sequencing error, but more likely insertion in an 
uncharacterized phage gene or laboratory strain difference.  
The disruption of gtrA, a glycosyltransferase, and yhhT, a permease, allowed growth of a 
fraB mutant in the presence of F-Asn. This suggests that these genes are important, and perhaps 
necessary, for the toxicity of F-Asn. Glycosyltransferases, such as gtrA, catalyze the biosynthesis 
of glycans [12]. To do so, a phosphate donor molecule, which can be a sugar phosphate, is 
transferred to an acceptor molecule. The accumulation of 6-P-F-Asp could lead to it entering 
biosynthetic pathways, and being incorporated into LPS or peptidoglycan. Incorporation of 6-P-
F-Asp instead of the normal substrate could lead to compromised cell wall stability, halting cell 
growth, and leading to the observed phenotype. 
This can be further examined by looking for a changed cell morphology in a fraB mutant 
when grown in minimal media with F-Asn. Though F-Asn is bacteriostatic to the fraB mutant, a 
compromised cell wall could lead to sensitivity to osmotic pressure. Subjecting the cells to 
osmotic pressure and observing lysis would further support this hypothesis.  
When disrupted, gtrA is unable to catalyze the reaction, suppressing the toxicity. The 
permease, yhhT, may play a role in relieving toxicity through influx of efflux of an intermediate 
of the operon, or a small molecule that interacts with a product of the operon. The function of the 
permease is unique to that of fraA, since fraA mutants are unable to grow on F-Asn, indicating 
there is no redundancy of transportation of F-Asp.  
Further changes can be made to improve the success of this project. To saturate the 
selection, a higher number of cultures will be started from the library, with and without 
tetracycline. 94 mutants will be selected by inoculating a 96-well plate containing minimal media 
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with F-Asn, glucose, and tetracycline with 2 μL of library. Two wells will serve as controls, with 
wild-type 14028 and the fraB mutant. The outgrowth will be struck to isolation, and a single 
colony will be chosen from each of the 94 plates. Growth in minimal media with F-Asn and 
glucose will be confirmed, and the transposon insertion sites will be identified using genomic 
DNA, or inverse PCR product if genomic DNA sequencing is unsuccessful. Increasing the 
number of colonies examined will ideally identify more mutations outside of the fra operon.  
Creation of a larger library is another long-term goal. 25,000 mutants should provide 
approximately 5.68X coverage of the Salmonella genome. This gives a 99.65% chance of each 
gene getting hit at least once, and a probability of missing a gene of 3.41x10-1 [13]. If coverage is 
increased to 10X, 99.99% of genes are hit at least once, and the probability of missing a gene 
decreases to 4.53x10-5, giving complete saturation of the genome. However, the multiple 








Figure 1.  The horizontally acquired fra island. The dark genes on the edges are orthologous to E. 
coli genes, while the light colored genes in the middle were presumably horizontally acquired 
since divergence from E. coli (or alternatively deleted from E. coli since divergence). fraR 
(STM14_4332) is a single gene that encodes a putative transcription regulator. fraBDAE appear 
to be an operon. fraB (STM14_4331) encodes a putative F-Asn deglycase. fraD (STM14_4330) 
encodes a putative sugar kinase. fraA (STM14_4329) encodes a putative F-Asp transporter. fraE 
















Figure 2. The proposed pathway of F-Asn metabolism. FraE cleaves F-Asn to F-Asp in the 
periplasm. FraA transports F-Asp into the cytoplasm, where it is phosphorylated to 6-P-F-Asp by 









Figure 3. A fraB mutant fails to grow in the presence of F-Asn. Wild-type (14028) and 
fraB80::kan (HMB206), were grown in M9 minimal media with either glucose or glucose and F-
Asn carbon sources at 37 ˚C for 18 hours. OD600 readings were taken every hour by a 







Figure 4. The growth of each mutant selected from the library in M9 minimal media with 
glucose and F-Asn carbon sources at 37 ˚C for 18 hours. OD600 readings were taken every hour 
by a SpecraMax® M5 Multi-Mode Plate Reader. Growth of all mutants fell in-between wild-





Figure 5. Growth of mutations transduced into a clean fraB mutant background (HMB206). 
Strains were grown in M9 minimal media with glucose and F-Asn carbon sources at 37 ˚C for 18 









Table 1. Co-transduction frequencies and distances from fraB. 
Mutant Co-transduction frequency 
Kanamycin resistant/total patched 
Distance from fraB based on 
cotransduction 
Distance from fraB based 
on DNA sequence 
BMH310 30/50; 60.0% 7,045 bp 24,497 bp 
BMH311 3/4; 75.0% 4,114 bp 2,396 bp 
BMH312 11/50; 22.0% 17834 bp 1,686,944 bp 
BMH313 50/50; 100% 0 bp 1,133 bp 
BMH315 33/44; 75% 4,114 bp Unknown 
BMH316 1/8; 12.5% 22,500 bp 2,629 bp 
BMH317 35/35; 100% 0 bp 3,058 bp 
BMH318 15/20; 75.0% 4,114 bp Unknown 
BMH319 20/20; 100% 0 bp 3,060 bp 














Table 2. Transposon insertion sites identified through sequencing and the function of the 
disrupted gene. 
Mutant Transposon Insertion Site Gene Function 
BMH310 STM14_4310; yhhT  permease 
BMH311 STM14_4329; fraA F-Asp transporter 
BMH312 STM14_0651; gtrA  glycosyltransferase 
BMH313 STM14_4330; fraD F-Asp kinase 
BMH317 STM14_4329; fraA F-Asp transporter 
BMH319 STM14_4329; fraA F-Asp transporter 















Table 3. Strains used. 
Strain name Genotype Source 
TH4881 LT2 pNK2880(CarbR, Tn10 tnpA[ats-1 ats-
2])/fliC5050::MudJ fljB5001::MudCm 
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S. enterica serovar 
Typhimurim 14028 
Wild-type American Type 
Culture Collection  
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